Spero Therapeutics, Inc.

SPRO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$52,889$76,333$109,107$112,584
Short-Term Investments$0$0$0$33,818
Receivables$52,476$50,697$1,084$2,641
Inventory$0$0-$4,463$0
Other Curr. Assets$1,911$4,178$3,379$8,829
Total Curr. Assets$107,276$131,208$109,107$157,872
Property Plant & Equip (Net)$3,114$4,157$5,492$7,556
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$46,590$0$0
Tax Assets$0$0$0$0
Other NC Assets$153$435$10,203$5,644
Total NC Assets$3,267$51,182$15,695$13,200
Other Assets$0$0$0$0
Total Assets$110,543$182,390$124,802$171,072
Liabilities
Payables$7,306$1,378$617$1,101
Short-Term Debt$1,746$1,718$1,690$1,362
Tax Payable$174$387$0$0
Deferred Revenue$22,124$27,113$10,369$1,857
Other Curr. Liab.$17,724$6,557$8,973$14,350
Total Curr. Liab.$49,074$37,153$21,649$18,670
LT Debt$2,551$3,825$4,957$5,973
Deferred Rev, NC$12,219$34,431$22,166$8,786
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$576$87$96$49,354
Total NC Liab.$15,346$38,343$27,219$64,113
Other Liabilities$0$0$0$0
Cap. Leases$4,297$3,825$6,647$7,335
Total Liabilities$64,420$75,496$48,868$82,783
Equity
Pref Stock$0$0$0$3
Common Stock$55$53$52$32
Retained Earnings-$459,638-$391,072-$413,878-$367,463
AOCI$0$0$0-$2
Other Equity$505,706$497,913$489,760$455,719
Total Equity$46,123$106,894$75,934$88,289
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$110,543$182,390$124,802$171,072
Net Debt-$48,592-$70,790-$102,460-$105,249
Spero Therapeutics, Inc. (SPRO) Financial Statements & Key Stats | AlphaPilot